Biotech Values

[ghmm]

In fairness to my guess the rate goes up if they decide not to copromote in the US (granted it sounds like InterMune isn't going to give that up). The Array royalty should not be counted against me too :), in fact I was suprised that they only have to pay half in the US (if they copromote) I would have expected all. Just so no one is suprised I am fairly certain Array will also get low-mid
single digits of Milestone payments too.

Thought there were just 5 preclinical candidates didn't realize they have a larger number! No one asked (and I assume not) but would InterMune get milestone payments equivalent to 191 on a second generation PI or just the royalty/profit share being equal.